Comparative Clinical Outcomes Between EGFR Ex20ins and Wildtype NSCLC Treated with Immune Checkpoint Inhibitors.

Girard, Nicolas; Minchom, Anna; Ou, Sai-Hong Ignatius; Gadgeel, Shirish M; Trigo, José; Viteri, Santiago; Bauml, Joshua M; Londhe, Anil; Mahadevia, Parthiv; Bazhenova, Lyudmila

Girard, Nicolas; Minchom, Anna; Ou, Sai-Hong Ignatius; Gadgeel, Shirish M; Trigo, José; Viteri, Santiago; Bauml, Joshua M; Londhe, Anil; Mahadevia, Parthiv; Bazhenova, Lyudmila.

Afiliación

Girard N; Institut Curie, Institut du Thorax Curie-Montsouris, Paris, France. Electronic address: nicolas.girard2@curie.fr.
Minchom A; Drug Development Unit, Royal Marsden/Institute of Cancer Research, Sutton, UK.
Ou SI; Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine, Orange, CA.
Gadgeel SM; Division of Hematology and Oncology, Department of Internal Medicine, Henry Ford Cancer Institute/Henry Ford Health System, Detroit, MI.
Trigo J; Hospital Universitario Virgen de la Victoria y Regional, IBIMA, Malaga, Spain.
Viteri S; UOMI Cancer Center, Clínica Mi Tres Torres, Barcelona, Spain.
Bauml JM; Division of Hematology/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Londhe A; Janssen Research and Development, Raritan, NJ.
Mahadevia P; Janssen Research and Development, Raritan, NJ.
Bazhenova L; University of California San Diego Moores Cancer Center, San Diego, CA.

Clin Lung Cancer ; 23(7): 571-577, 2022 11.

Article en En | MEDLINE | ID: mdl-36085282

Asunto(s)

Carcinoma de Pulmón de Células no Pequeñas; Neoplasias Pulmonares; Humanos; Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico; Carcinoma de Pulmón de Células no Pequeñas/genética; Carcinoma de Pulmón de Células no Pequeñas/patología; Receptores ErbB/genética; Inhibidores de Puntos de Control Inmunológico/uso terapéutico; Neoplasias Pulmonares/tratamiento farmacológico; Neoplasias Pulmonares/genética; Neoplasias Pulmonares/patología; Mutación/genética; Estudios Retrospectivos

Palabras clave

Immunotherapy; Mutation; Real-world data; Real-world overall survival; Time to next treatment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google